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SUMMARY
Transcriptional termination of mammalian RNA poly-
merase II (Pol II) requires a poly(A) (pA) signal and,
often, a downstream terminator sequence. Termina-
tion is triggered following recognition of the pA signal
by Pol II and subsequent pre-mRNA cleavage, which
occurs either at the pA site or in transcripts from
terminator elements. Although this process has
been extensively studied, it is generally considered
inconsequential to the level of gene expression.
However, our results demonstrate that termination
acts as a driving force for optimal gene expression.
We show that this effect is general but most dramatic
where weak or noncanonical pA signals are present.
We establish that termination of Pol II increases the
efficiency of pre-mRNAprocessing that is completed
posttranscriptionally. As such, transcripts escape
from nuclear surveillance.
INTRODUCTION
We recently presented a dissection of the events that lead to
mammalian RNA polymerase II (Pol II) termination (West et al.,
2008). During the termination process, the poly(A) (pA) signal is
recognized by Pol II and transcripts are cleaved to present an un-
capped substrate for 50/30 exonucleases (Kaneko et al., 2007;
Kim et al., 2004; West et al., 2004). Degradation of the trailing
transcript precedes termination, where the Pcf11 protein may
play a key role (Luo et al., 2006; West and Proudfoot, 2008;
Zhang and Gilmour, 2006). At least two closely related termina-
tion pathways exist that differ in the primary nascent RNA
cleavage event, which depends on the downstream terminator
(West et al., 2008). Some terminators act to pause Pol II, and in
this case cleavage at the pA site acts as the 50/30 exonuclease
entry site and precedes termination. Transcripts from other
terminators, such as that downstream of the human b-globin
gene, are cotranscriptionally cleaved directly over the terminator
sequence (Dye and Proudfoot, 2001). In this case, pA site
cleavage occurs on transcripts subsequently released from the
template DNA after Pol II has terminated.
Many aspects of pre-mRNA processing and transcription are
known to influence gene expression (Proudfoot et al., 2002).
Transcripts are capped at their 50 ends to protect them from
50/30 degradation; the splicing reaction competes with degra-
dation pathways, which target unspliced transcripts (Bous-
quet-Antonelli et al., 2000); and 30 end processing is important,
because transcripts that fail to be cleaved and polyadenylated
properly are retained in the nucleus and degraded (Hilleren
et al., 2001; Milligan et al., 2005; Saguez et al., 2008; Vodala
et al., 2008). The most obvious way that transcription impacts
on gene expression levels is through the rate of Pol II initiation,
which can be modulated by combinations of promoter or
enhancer strength and trans-activating factors (Kadonaga,
2004). Elongation rate may also determine gene expression
patterns by influencing alternative splicing (Cramer et al.,
1997). Failed termination on a gene can impair the expression
of downstream genes by reducing the accessibility of the
promoter to Pol II (Greger et al., 2000). This process, known as
transcriptional interference, is particularly relevant in lower
eukaryotes, as they often have closely spaced genes. Whereas
transcriptional interference reduces the expression of the down-
stream gene, failure to terminate transcription of the upstream
gene is not thought to affect its own expression. Furthermore,
it may be of little relevance in higher eukaryotes where most
genes are positioned far apart. Significantly, we now show that
transcriptional termination on a gene is required for its own
optimal expression.
RESULTS
The b-Globin Terminator Enhances Gene Expression
To analyze the effect of termination on gene expression, we used
thewell-characterized human b-globin gene. Two plasmids were
employed (Figure 1A): one containing the b-globin gene and its
terminator sequence (bTERM) and one without the terminator
(bDTERM), the absence of which dramatically reduces termina-
tion efficiency (Dye and Proudfoot, 2001). In both cases, tran-
scription is driven by the HIV promoter, transactivated by Tat.
HeLa cells were transfected with bTERM or bDTERM along
with a cotransfection control plasmid encoding the adenovirus
VA RNA. To measure b-globin mRNA expression, nuclear and
cytoplasmic mRNA was analyzed using real-time PCR analysis
(Figure 1A). In the presence of the terminator element (bTERM),
levels of both nuclear and cytoplasmic b-globin mRNA were
enhanced. We previously observed little difference in b-globin
mRNA levels from these constructs, using probe-based RNA
mapping techniques (Gromak et al., 2006). We suspect that
b-globin mRNA was in excess of the probe level used in these
experiments, and tested this assumption by using a large excess
of probe to analyze b-globin mRNA by northern blot (Figure 1B).
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This experiment also revealed an enhancing effect of Pol II termi-
nation.
We next analyzed the effect of termination on the levels of
b-globin protein. HeLa cells were transfected with bTERM or
bDTERM and a control plasmid expressing an HA-tagged
protein (RBM21) which measures transfection efficiency.
Following this, b-globin and RBM21 proteins were detected by
western blotting (Figure 1C). Similar levels of RBM21 protein
were detected in each case, demonstrating equal transfection
efficiency. However, 10-fold more b-globin protein was detected
in the bTERM protein sample as compared to the bDTERM
sample. We note that this is a greater effect than seen at the
mRNA level, which may reflect additional translational regula-
tion. These data indicate a positive function for termination in
gene expression.
On bDTERM, Pol II does not terminate efficiently and so may
reduce new rounds of initiation (and gene expression) by reading
around the plasmid and back into the promoter sequence,
causing transcription interference. To measure interference, we
performed hybrid selection nuclear run-on (NRO) analysis (Dye
and Proudfoot, 1999) on HeLa cells transfected with bDTERM
and VA (Figure 1D). Radiolabeled nascent transcripts were
hybridized to a biotinylated probe complementary to the U3
region of the HIV promoter. U3 is upstream of the promoter (P)
region and therefore only transcribed by Pol II that fails to termi-
nate and reads around the plasmid. Selection of the RNA hybrids
with streptavidin-coated magnetic beads purifies transcripts
continuouswith theU3 region, which include P transcripts result-
ing from readthrough transcription. P transcripts deriving from
new rounds of initiation will not be selected (see diagram).
Selected transcripts (S) and those that escaped selection (NS)
were hybridized to separate filters containing antisense M13
DNA probes. The majority of U3 signal was in the selected frac-
tion, demonstrating efficient selection. Even so, most P signal
was not selected, showing that it mainly derives from new rounds
of initiation and not from readthrough transcription. Importantly,
we controlled against RNA degradation as a cause for the
appearance of P signal in the NS fraction (see Figure S1 available
online). We repeated the experiment on bTERM transfected
HeLa cells (Figure 1D) and no U3 transcripts were selected,
presumably because termination prevents readthrough tran-
scription into the U3 sequence. Quantitation of the P signals in
the NS bTERM and bDTERM fractions, relative to VA, revealed
that transcription interference only reduces initiation to 67%.
Consequently, only 33% of the P signal is due to transcriptional
readthrough. This result was also confirmed by analysis of linear
templates (Figure S2). Together, these data exclude the possi-
bility that a transcriptional interference effect accounts for the
changes in protein and mRNA levels.
Enhancement of Gene Expression Is a General Function
of Terminators
We next analyzed the effect of three other terminator elements
on gene expression: the mouse serum albumin (MSA) terminator
A B
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Figure 1. The b-Globin Terminator En-
hances Gene Expression
(A) The upper diagram shows bTERM. Promoter
(arrow), exons (white box), pA signal (pA), and
terminator (TERM) are shown. Distances between
the pA site and terminator and the length of the
terminator are shown. The lower diagram shows
b-globin mRNA and the primers used for reverse
transcription (dT) and real-time PCR (e2f/e3r)
detection. The graph shows the relative level of
nuclear and cytoplasmic b-globin mRNA from
bDTERM and bTERM samples, after equalizing
to VA levels. mRNA levels were set at 1 for
bDTERM. Error bars show standard deviation
from the mean (SDM).
(B) Northern blot analysis of cytoplasmic RNA
from bTERM and bDTERM samples. mRNA levels
are shown (bDTERM is given a value of 1). SDM is
shown.
(C) Western blot analysis of HeLa cells transfected
with bDTERM or bTERM as well as the RBM21
expression construct. b-globin and RBM21
proteins are indicated. Quantitation is shown
where bDTERM is given a value of 1.
(D) Hybrid selection NRO analysis of HeLa cells
transfected with bDTERM or bTERM as well as
VA. Diagrams show U3 and P regions of the HIV
promoter. The selection probe (black) selects U3
transcripts and promoter (P) transcripts that result
from readthrough transcription (left diagram). P
transcripts resulting from newly initiated Pol II
are not selected (right diagram). The top data panels show transcripts not selected by probe (NS) and the lower panels show selected (S) transcripts. NRO
M13 probes are shown above the relevant slot. Percent initiation is shown and given a value of 100% for bTERM. M is an empty M13 vector that shows back-
ground signal. SDM is shown.
Molecular Cell
Pol II Termination Enhances Gene Expression
Molecular Cell 33, 354–364, February 13, 2009 ª2009 Elsevier Inc. 355
region (West et al., 2006b), the engineered MAZ4, and the
reverse MAZ4 (ZAM4) (Gromak et al., 2006) sequences. MSA
terminator transcripts are cotranscriptionally cleaved like those
from the b-globin element (West et al., 2006b), whereas termina-
tion at MAZ4 and ZAM4 requires prior pA site cleavage (Gromak
et al., 2006; West et al., 2008). These elements were cloned in
place of the b-globin terminator to form balbTERM, bMAZ4,
and bZAM4, which were transfected into HeLa cells. Nuclear
and cytoplasmic b-globin mRNA was then quantitated
(Figure 2A). The presence of any of the three terminator elements
significantly enhanced b-globin mRNA levels as compared to
bDTERM (Figure 2A). b-globin protein levels were also enhanced
in each case (Figure 2B).
A termination-independent function for these sequences in
pre-mRNA processing is unlikely. They share no apparent
sequence homology, and the MAZ4 element has no effect on
the processing of a synthetic pre-mRNA in vitro (Yonaha and
Proudfoot, 1999). We therefore predict that their shared function
in termination is responsible for enhanced gene expression. To
test this more thoroughly, we employed a construct containing
a mutated MAZ4 element (bmMAZ4) which is the same length
as the MAZ4 element but does not promote Pol II termination
(Gromak et al., 2006). We tested protein production from
bmMAZ4, bMAZ4, and bDTERM (Figure 2C). As before,
3-fold more b-globin protein was observed for bMAZ4 as
compared to bDTERM, whereas identical protein expression
was observed for bDTERM and bmMAZ4. Thus, consistent
with its inability to promote Pol II termination, the mutant MAZ4
element does not enhance protein expression. This result rein-
forces the view that termination enhances gene expression.
Termination Enhances Gene Expression Irrespective
of the pA Signal Used
The other cis-acting sequence required for termination is the pA
signal (Whitelaw and Proudfoot, 1986). It is generally thought that
the rate of processing at the pA site correlates with termination
efficiency and is a key determinant of gene expression levels (Ed-
walds-Gilbert et al., 1993).Weexplored the effects of theb-globin
terminator element in the presence of pA signals that are pro-
cessed relatively inefficiently. We replaced the b-globin pA signal
in bTERM and bDTERM with either the MSA or the human
PMScl100 pA signal, forming ATERM, ADTERM, PMTERM, and
PMDTERM. We have shown that the MSA pA signal is inefficient
(West et al., 2006b) and that the PMScl100 pA signal contains an
AUUAAA sequence instead of the consensus AAUAAA hexamer,
which would be predicted to reduce its efficiency.
To compare the relative efficiencies of the b-globin, MSA, and
PMScl100 pA signals, we performed a pA site competition assay
on three constructs containing either of the three test pA signals
followed by a synthetic pA signal (SPA) (Figure 3A). The SPA is
only processed if the competing upstream site is relatively
weak. HeLa cells were transfected with the three competition
constructs (called bpA, MSApA, and PMScl100pA) and cyto-
plasmic RNA was isolated. Processing at the proximal test pA
site and the distal SPA was then quantitated by RT-PCR. As
compared to bSPA, 7- to 10-fold more processing at the SPA
was observed when the MSA or the PMScl100 pA signal was
positioned upstream. This result confirms our previous data
demonstrating that MSA pA is weak (West et al., 2006b) and
also shows that the PMScl100 pA signal is relatively weaker
than the b-globin signal. Termination was then analyzed on
ATERM, ADTERM, PMTERM, and PMDTERM using NRO
(Figure 3B). As expected, this is inefficient on ADTERM and
PMDTERM shown by the high signals over probes A and U3,
which detect transcripts from Pol II that fails to terminate.
Surprisingly, termination was very efficient on both ATERM and
PMTERM, as shown by the low A and U3 signals. Thus, in this
system, the b-globin terminator element promotes efficient
termination irrespective of pA signal strength.
Next, we analyzed nuclear and cytoplasmic b-globin mRNA in
HeLa cells transfected with ATERM, ADTERM, PMTERM, or
PMDTERM (Figure 3C). We observed 4-fold more nuclear
and 8-fold more cytoplasmic b-globin mRNA from ATERM as
compared to ADTERM and 10- to 15-fold more nuclear and
A 
B 
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Figure 2. Gene Expression Is Enhanced by Different Terminators
(A) RT-PCR analysis of nuclear and cytoplasmic b-globin mRNA from HeLa
cells transfected with bDTERM, balbTERM, bMAZ4, or bZAM4. Primers are
as in Figure 1A. The graph shows b-globin mRNA values (bDTERM is set to
1). Error bars show SDM.
(B)Western blot analysis of HeLa cells transfectedwith bDTERMor balbTERM,
bDTERM or bMAZ4, and bDTERM or bZAM4 together with RBM21. b-globin
and RBM21 proteins are indicated and quantitated. SDM is shown.
(C) Western blot analysis of HeLa cells transfected with bDTERM, bmMAZ4, or
bMAZ4. b-globin and RBM21 proteins are indicated and quantitated. SDM is
shown.
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cytoplasmic b-globin mRNA in PMTERM samples as compared
to PMDTERM samples. A substantial increase in protein levels
was also observed (Figure 3D). These experiments reveal that
termination can enhance gene expression evenmore in the pres-
ence of weak pA signals.
The effects of the b-globin terminator on gene expression from
weak and strong pA signals were then directly compared. HeLa
cells were transfected with bDTERM, bTERM, ADTERM, or
ATERM and nuclear and cytoplasmic b-globin mRNA was
analyzed (Figure 3E). Comparison of bDTERM and ADTERM
samples revealed similar levels of nuclear mRNA, but levels of
cytoplasmic mRNA were lower for ADTERM, consistent with the
weaker MSA pA. However, both nuclear and cytoplasmic levels
of b-globin mRNA were similar in bTERM and ATERM samples,
albeit much greater thanwith inefficient termination. Again, these
results were confirmed at the protein level (Figure 3F). Thus, the
b-globin terminator enhances gene expression from the MSA
pA signal more than for the b-globin pA signal. As such, mRNA
levels correlate more with termination efficiency than pA signal
strength.
The above result was unexpected, because it has been sug-
gested that gene expression correlates with pA signal strength
(Edwalds-Gilbert et al., 1993). These data are rationalized by
our recent observation thatmammalianPol II termination requires
cleavage of nascent RNA, either within terminator transcripts or
at the pA site (West et al., 2008). In the former case, pA site
cleavage is not necessary for the termination process. Therefore,
the inefficientMSAorPMScl100pAsignals donot reduce theeffi-
ciency of Pol II termination. This predicts thatweak pA signalswill
only inhibit termination when pA site cleavage is solely
A E
F
G
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C
D
Figure 3. Termination Enhances Gene
Expression Irrespective of the pA Signal
Used
(A) HeLa cells were transfected with constructs
containing the b-globin (bpA), MSA (MSApA), or
PMScl100 (PMScl100pA) pA signals upstream of
the SPA. Diagrams show the primers used for
reverse transcription (dT) and PCR of proximal
(e3f/e3r) or distal (SPAf/pAR) signals. pA signal
strength was determined as a ratio of mRNA pro-
cessed at either the proximal (P) or distal (D) pA
signal. bpA is given a value of 1. Error bars show
SDM.
(B) NRO analysis of HeLa cells transfected with
ADTERM, ATERM, PMDTERM, or PMTERM.
M13 probes are shown above the relevant slot
and their position on the plasmid is shown in the
diagram. Relative termination was quantitated
by dividing the signal over readthrough probes A
and U3 by those for probes P, B3, and B4. Values
are set to 1 for ADTERM and PMDTERM.
(C) RT-PCR analysis of nuclear and cytoplasmic
b-globin mRNA from HeLa cells transfected with
ADTERM, ATERM, PMDTERM, or PMTERM.
Primers are as in Figure 1A. Values for the DTERM
constructs are set at 1. Error bars show SDM.
(D) Western blot analysis of b-globin protein in
HeLa cells transfected with ADTERM or ATERM
(left blot) and PMDTERM or PMTERM (right blot).
b-globin and RBM21 control proteins are indi-
cated and quantitated.
(E) RT-PCR analysis of nuclear and cytoplasmic
b-globin mRNA from HeLa cells transfected with
bDTERM, ADTERM, bTERM, or ATERM. Primers
are as in Figure 1A. Error bars show SDM.
(F) Western blot analysis of b-globin and RBM21
proteins in HeLa cells transfected with bDTERM,
ADTERM, bTERM, or ATERM. The lower panel
on the left-handsidewasexposed for longer, given
the lower levelsofb-globinpresent. SDM is shown.
(G) NRO analysis of AMAZ4. M13 probe positions
are shown in (B). The table shows quantitation
(performed as for [B]) of the experiment and,
for comparison, others on bTERM, bDTERM,
bMAZ4, ADTERM, and ATERM. SDM is shown.
(H) Western blot analysis of b-globin and RBM21
proteins in HeLa cells transfected with ADTERM
or AMAZ4. SDM is shown.
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responsible for nascent RNA cleavage, as we have shown for
termination over MAZ4 (Gromak et al., 2006). These data are
extended in Figure 3G, where the b-globin terminator in ATERM
was replacedwith theMAZ4 element and NRO analysis was per-
formed. As predicted, the MAZ4 sequence promotes only partial
termination beyond the weak MSA pA signal (Figure 3G).
Nevertheless, termination on AMAZ4 is more efficient than
on ADTERM, and this still enhances protein expression
(Figure 3H). It should be noted that hybrid selection NRO shows
that the enhanced gene expression seen with weak pA signals
cannot be accounted for by promoter interference (Figure S3).
Termination Dramatically Enhances Erythropoietin
Expression
The data so far show that Pol II termination is required for optimal
b-globin expression. We next analyzed the effects of Pol II termi-
nation on the expression of a different human gene, erythropoi-
etin (EPO). EPO does not contain a recognizable pA signal and
A D
B E
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Figure 4. Termination Enhances Erythro-
poietin Expression
(A) The diagram shows ETERMwith nomenclature
as for bTERM. The graph shows RT-PCR quanti-
tation of readthrough RNA in HeLa cells trans-
fected with EDTERM or ETERM. The value for
EDTERM was set at 1. Primers used for reverse
transcription (RTr) and PCR (RTf/RTr) are shown
in the diagram. Error bars show SDM.
(B) RT-PCR quantitation of nuclear and cyto-
plasmic EPO mRNA from HeLa cells transfected
with EDTERM or ETERM as well as VA. Values
for EDTERM are set at 1. The diagram shows
primers used for reverse transcription (dT) and
PCR (EPf/EPr). Error bars show SDM.
(C) Western blot analysis of EPO protein secreted
from HeLa cells transfected with EDTERM or
ETERM. EPO and the RBM21 control protein are
indicated. Quantitation is shown (EDTERM is
given a value of 1).
(D) RT-PCR quantitation of readthrough RNA from
CbDTERM, CbTERM, CEDTERM, or CETERM.
The DTERM samples are given a value of 1.
Primers are as in (A). Error bars show SDM.
(E) RT-PCR analysis of cytoplasmic b-globin and
EPO mRNA in HeLa cells transfected with
CbDTERM, CbTERM, CEDTERM, or CETERM.
The DTERM samples are given a value of 1. The
diagrams show primers for reverse transcription
(dT) and PCR (e2f/e3r for b-globin and EPf/EPr
for EPO). Error bars show SDM.
(F) Western blot analysis of EPO protein from
HeLa cells transfected with CEDTERM or
CETERM. EPO and the RBM21 control protein
are indicated and quantitated. SDM is shown.
instead uses an AAGAAC hexamer (Lin
et al., 1985). This would not normally be
expected to function, considering that
singlemutations in the AAUAAA hexamer
are often enough to inactivate 30 end pro-
cessing (Sheets et al., 1990). Neverthe-
less, polyadenylated species were previously observed corre-
sponding to use of this site (Lin et al., 1985), and we confirmed
its use in our system by 30 RACE (data not shown). Given the
strong effects of termination on gene expression from weak pA
signals, EPO provides a valuable further test of our findings.
EPO was cloned into bDTERM and bTERM in place of the
human b-globin gene, still retaining the HIV promoter, forming ED
TERM and ETERM, respectively. These constructs and VA were
transfected into HeLa cells and efficient termination on ETERM
was confirmed by using a previously described RT-PCR assay
that recapitulates NRO analysis (West and Proudfoot, 2008).
Nuclear RNA was isolated and reverse transcribed with primer
RTr, and cDNA was real-time PCR amplified using primers RTr
and RTf to detect RNA beyond the terminator region (Figure 4A).
Weobserved10-fold less readthroughRNA forETERM (indicative
of efficient termination) as compared to EDTERM.
We next analyzed nuclear and cytoplasmic EPO mRNA from
HeLa cells transfected with EDTERM or ETERM together with
Molecular Cell
Pol II Termination Enhances Gene Expression
358 Molecular Cell 33, 354–364, February 13, 2009 ª2009 Elsevier Inc.
VA (Figure 4B). As for b-globin, we observed much higher levels
of nuclear (8-fold) and cytoplasmic (15-fold) EPO mRNA in the
ETERM sample as compared to EDTERM. Levels of secreted
EPO protein were also much greater (over 30-fold) for ETERM
as compared to EDTERM (Figure 4C). These data match our
finding that termination dramatically enhances gene expression
from weak pA signals and provides evidence that transcriptional
termination is generally required for optimal gene expression.
Termination Enhances Gene Expression Independent
of the Promoter
We next investigated whether termination enhances gene
expression in the context of a different promoter with distinct
properties to the HIV promoter. The CMV promoter was chosen
as it supports high levels of transcription but induces relatively
slow elongation (Cramer et al., 1997). This contrasts with the
HIV promoter, activated by Tat, which promotes highly proces-
sive Pol II elongation (Nogues et al., 2002; Parada and Roeder,
1996). We replaced the HIV promoter in bTERM, bDTERM,
ETERM, and EDTERMwith the CMV promoter, to formCbTERM,
CbDTERM, CETERM, and CEDTERM, respectively. We
analyzed termination efficiency on these constructs using RT-
PCR to quantitate readthrough RNA (Figure 4D). There was little
difference in the level of readthrough RNAbetweenCbTERMand
CbDTERM, which indicates that termination is equally efficient
on these constructs. However, we observed significantly less
readthrough RNA from CETERM as compared to CEDTERM,
indicating a difference in termination efficiency. These data
suggest that termination of the b-globin gene does not require
a terminator when transcription is from the CMV promoter, but
a terminator is still required to terminate transcription of the
EPO gene. Because CMV-driven transcription is relatively non-
processive, the strong b-globin pA signal is sufficient to induce
termination without additional elements. In contrast, the nonca-
nonical EPO pA signal still requires the terminator sequence for
efficient termination.
If termination enhances gene expression, the above results
predict that no difference in expression would be observed
between CbTERM and CbDTERM because the process is
equally efficient on each construct. However, expression should
be greater for CETERM than for CEDTERM, because the termi-
nator element improves termination on this construct. This was
tested by transfecting HeLa cells with CbTERM, CbDTERM,
CETERM, or CEDTERM and measuring cytoplasmic mRNA
levels (Figure 4E). Little difference in b-globin mRNA levels was
observed between the CbTERM and CbDTERM samples,
showing that the b-globin terminator does not further enhance
gene expression if termination is already efficient. Crucially,
2.5-fold more EPO mRNA was recovered from the CETERM
samples as compared to CEDTERM, and a corresponding
increase in EPO protein expression was observed (Figure 4F).
These effects on EPO expression are not as great as those
observed with the HIV promoter. However, this is in line with
the fact that the difference in termination between CETERM
and CEDTERM is also less than that between ETERM and
EDTERM (compare Figures 4A and 4D). We conclude that,
whereas a terminator is not always necessary for termination
when transcription is driven by the CMV promoter, it remains
the case that an enhanced termination process increases gene
expression. This important observation shows that increasing
termination enhances gene expression irrespective of the
promoter.
Mechanism of Increased Gene Expression by Efficient
Pol II Termination
We sought to establish why termination enhances gene expres-
sion. Figure 1D shows that inefficient termination only reduces
transcription initiation efficiency, through interference effects,
by 33%. Yet, we demonstrate a significantly larger reduction of
gene expression, implying that synthesized transcripts are
degraded before they are translated. The surveillance mecha-
nism is likely to be a nuclear process because nuclear mRNA
levels are affected.
It is well established that Pol II transcription and pre-mRNA
processing are coupled (Proudfoot et al., 2002). Because
removal of terminator elements inhibits gene expression, we
tested whether pre-mRNA splicing efficiency is also reduced.
b-globin pre-mRNA splicing was analyzed in HeLa cells trans-
fected with bTERM and bDTERM (Figure 5A). To be confident
that changes are due to termination, we also analyzed CbTERM
and CbDTERM, which share the same sequence differences as
bTERM and bDTERM but support similar levels of termination
(Figure 4D). Nuclear RNA was reverse transcribed with dT to
detect cleaved and polyadenylated transcripts, with primer I2r
to detect unspliced transcripts or with pAR to detect transcripts
not yet cleaved at the pA site. These cDNAs were amplified with
primers e1f and e2r to detect spliced (S) and unspliced (US) RNA
(Figure 5A). For the dT primed cDNA, only spliced RNA was de-
tected in each case, indicating that the majority of cleaved and
polyadenylated transcripts are also spliced. We next amplified
the I2r and pAR cDNA with primers e1f and e2r to analyze the
splicing status of pre-mRNAs. A higher ratio of spliced to un-
spliced transcripts was recovered from bTERM samples as
compared to bDTERM. Because the ratio of spliced and un-
spliced transcripts was similar for CbTERM and CbDTERM,
which both terminate equivalently, termination is likely to
account for splicing differences between bTERM and bDTERM.
We next analyzed splicing of intron 2 using the same RNA
samples. Because intron 2-retaining pre-mRNAs are more than
1 kilobase larger than spliced transcripts, primers spanning
this region are susceptible to PCR competition. To circumvent
this, intron 2-retaining and spliced transcripts were detected
from the same pAR primed cDNA, using separate PCR primer
pairs: e2f/e3r and e2f/I2r to detect spliced and unspliced tran-
scripts, respectively (Figure 5B). There was a higher ratio of
spliced to unspliced transcripts for bTERM as compared to
bDTERM. Again, a similar ratio was observed for CbTERM and
CbDTERM. We conclude that termination enhances splicing of
both b-globin gene introns.
A potential criticism of the above result could be that pre-
mRNA is degraded in the bTERM sample more efficiently than
for bDTERM. This is unlikely, given the lack of change between
CbTERM and CbDTERM samples. Even so, we repeated our
analysis on a further two constructs (bDTERM1m and
bTERM1m) which contain a mutated first intron (Figure 5C).
This mutation prevents splicing but not termination (Dye and
Molecular Cell
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Proudfoot, 1999), and so allows us to look at differences in the
stability of the two pre-mRNAs. Only unspliced transcripts
were observed in the analysis and the abundance of pAR and
I2r primed cDNAs was unchanged, showing that these pre-
mRNAs do not have significantly different stabilities.
The Effect of Termination on Pre-mRNA Splicing
Is Posttranscriptional
The enhanced splicing as a result of termination suggests a post-
transcriptional effect. We therefore analyzed cotranscriptional
splicing on bTERM and bDTERM using a modified NRO protocol
to incorporate bromo-labeled UTP (brU) into nascent RNAs
which were purified using a brU-specific antibody (Lin et al.,
2008). We purified brU-labeled RNA from HeLa cells transfected
with bTERM or bDTERM and examined the levels of transcripts
containing intron 1 and intron 2 (Figure 5D). Cotranscriptional
splicing is expected to reduce the level of intron-containing
RNAs that are recovered. cDNA was synthesized with primers
e2r or e3r and PCR amplification was with the e1f/I1r or e2f/I2r
primer pairs to detect intron 1 and intron 2, respectively. After
subtracting the background, obtained from minus antibody
controls, we observed little difference in the levels of intron 1
and intron 2 between the bTERM and bDTERM samples. We
also directly analyzed spliced exons 2 and 3 but recovered no
above-background signal (data not shown and Figure S4). These
data reveal little difference in the cotranscriptional splicing of
bTERM and bDTERM transcripts. The difference in the levels of
spliced transcripts observed in total nuclear bTERM and
bDTERM samples is therefore likely to reflect posttranscriptional
splicing as a result of termination.
The Exosome Degrades Some Transcripts When
Termination Is Inefficient
We next asked what degrades the transcripts when termination
is inefficient. To this end, we depleted the nuclear exosome
subunit PMScl100 using RNA interference (RNAi). Western blot
analysis of PMScl100 protein in cells that had beenmock treated
or transfected with PMScl100-specific siRNAs showed that
levels were depleted by 2- to 3-fold (Figure 6A). Equal levels of
actin were observed showing that loading was equivalent. These
data were substantiated by quantitative RT-PCR analysis of
PMScl100 mRNA, which was reduced to 38%. We observed
a similar effect with a further two PMscl100-specific short hairpin
RNAs (data not shown), which also resulted in similar pheno-
types to those described below.
The effect of this depletion was tested in situations where
termination and splicing are inefficient and for strong and weak
pA signals. Mock and PMScl100-depleted cells were
A D
B
C
Figure 5. Termination Enhances Pre-mRNA
Splicing
(A) RT-PCR analysis of intron 1 splicing in HeLa
cells transfected with bTERM, bDTERM,
CbTERM, or CbDTERM. The diagram shows posi-
tions of the primers used in this experiment. The
primer used for cDNA synthesis is indicated in
brackets beside each panel with the PCR primer
pair indicated to its left. Unspliced (US) and
spliced (S) products are indicated. Real-time
PCR quantitation of the ratio of spliced to un-
spliced (S/US) is shown. SDM is shown.
(B) RT-PCR analysis of intron 2 in HeLa cells trans-
fected with bTERM, bDTERM, CbTERM, or
CbDTERM. Primers are indicated as in (A). It
should be noted that different cycle numbers
were used for the separate PCR reactions. Real-
time PCR quantitation of the ratio of spliced to
unspliced (S/US) is shown. SDM is shown.
(C) RT-PCR analysis of pre-mRNA stability in
HeLa cells transfected with bTERMm1 or
bDTERMm1. Primers are indicated as in (A).
Real-time PCR quantitation is shown. SDM is
shown.
(D) BrUNRO analysis of cotranscriptional splicing.
The top diagrams show the procedure, where
immunoprecipitation of brU (star) detects cotran-
scriptional splicing (right) or introns that are not
spliced during transcription (left). The lower
diagrams show the primers used for reverse tran-
scription (e2r and e3r) and PCR (e1f/I1r and e2f/
I2r) to detect intron 1 and 2, respectively. Quanti-
tation shows the signal (set at 1 for bDTERM) ob-
tained after subtracting the minus antibody
control value. Error bars show SDM.
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transfected with bDTERM or ADTERM and levels of cytoplasmic
b-globin mRNA were analyzed by RT-PCR (Figure 6B). We
observed increased levels of cytoplasmic mRNA in PMScl100-
depleted cells as compared to mock treated cells, identifying
PMScl100 as part of the mechanism that suppresses gene
expression when termination is inefficient. Interestingly, the
effect of exosome depletion was greater for ADTERM than for
bDTERM. This is in line with our finding that termination
enhances gene expression to a greater degree for weaker pA
signals. PMScl100 depletion has little effect on bTERM mRNA
levels (West et al., 2006a), which is consistent with the termina-
tion process reducing the susceptibility of transcripts to degra-
dation. Depletion of the cytoplasmic exonuclease Xrn1 had little
effect on mRNA levels (data not shown), confirming a nuclear
surveillance process.
We next determined the timing of degradation in relation to 30
end processing. Mock and PMScl100-depleted cells were trans-
fected with ADTERM, and RNA samples were reverse tran-
scribed with pAR (to detect uncleaved) or dT (to detect cleaved
and polyadenylated RNAs). Subsequent PCR was with the e3f
and e3r primer pair (Figure 6C). As before, PMScl100 depletion
substantially increased the level of RNA cleaved at the pA site
(dT primed). However, there was much less of an effect on
A D
B
C
Figure 6. The Exosome Degrades Tran-
scripts When Termination Is Inefficient
(A) Western blot analysis of PMScl100 and actin
proteins from mock treated and PMScl100-
depleted HeLa cells. Quantitation of PMScl100
mRNA is shown underneath. SDM is shown.
(B) Analysis of cytoplasmic b-globin mRNA in
mock treated or PMScl100-depleted HeLa cells
transfected with bDTERM or ADTERM. The graph
shows the fold increase in cytoplasmic mRNA in
PMScl100-depleted cells as compared to mock
treated cells. Error bars show SDM.
(C) RT-PCR analysis of nuclear mRNA and pre-
mRNA in HeLa cells transfected with ADTERM.
The diagrams show the target species (30 end pro-
cessed RNA on the left and RNA, not cleaved at
the pA site, on the right). Primers used for reverse
transcription (pAR and dT) and PCR (e3f/e3r) are
also shown. The graph shows relative RNA levels
(the value for mock treated cells is 1). Error bars
show SDM.
(D) RT-PCR analysis of chromatin-associated
(black) and released (white) nuclear b-globin
mRNA isolated from HeLa cells transfected with
bDTERM, ADTERM, bTERM, or ATERM. Primers
are as in Figure 1A. The proportion of mRNA in
each fraction is shown superimposed onto the
levels of total nuclear b-globin mRNA obtained
from the experiment shown in Figure 3E. Error
bars show SDM.
uncleaved transcripts. These data show
that PMScl100 targets ADTERM tran-
scripts for degradation after cleavage at
the pA site. Presumably, the exosome
requires free RNA termini to degrade
a transcript. For ADTERM, and other cases where there is no
terminator transcript cleavage, this is primarily provided by pA
site cleavage. Where terminator transcripts are cleaved, we
have shown this to provide additional targets for the exosome
(West et al., 2006a).
Collectively, the above results show that inefficient termination
promotes the degradation of transcripts by the exosome after pA
site cleavage. These data predict that termination releases
mRNA from this decay, which can exist close to transcription
sites (Hilleren et al., 2001). We finally employed a technique
that separates chromatin-associated transcripts from those
released into the nucleoplasm (West et al., 2008). We included
constructs with either strong or weak pA signals in the analysis.
Nuclei were isolated from HeLa cells transfected with bDTERM,
ADTERM, bTERM, or ATERM, fractionated into chromatin-asso-
ciated and released fractions, and analyzed using RT-PCR
(Figure 6D). RNA was reverse transcribed with dT and then
real-time PCR amplified with primers e3f and e3r to detect all
polyadenylated species, both spliced and unspliced. Similar
levels of chromatin-associated polyadenylated RNAwere recov-
ered in each case (black section of bar) but much more released
polyadenylated RNA was present in the bTERM and ATERM
samples (white section of bar). This again suggests that release
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of transcripts by termination enhances gene expression. The
relevance of this observation to the enhanced gene expression
is emphasized by the close correlation between the levels of
released polyadenylated RNA and cytoplasmic mRNA (compare
Figures 6D and 3E).
DISCUSSION
The data presented in this study show that termination releases
transcripts from the DNA template, which promotes their pro-
cessing and subsequent gene expression. Previous studies
identified the pA signal as a key determinant of gene expression
levels and termination efficiency (Edwalds-Gilbert et al., 1993).
Although consistent with these data, we show that weak pA
signals have no effect on the termination process when the
b-globin terminator is used in conjunction with the HIV promoter.
This is presumably because cleavage of terminator transcripts
obviates the need to cleave at the pA site by enabling termination
to occur irrespective of pA signal strength. When termination is
reliant on pA site cleavage, the strength of the pA signal deter-
mines its efficiency (Edwalds-Gilbert et al., 1993; Gromak
et al., 2006; Orozco et al., 2002).
Our studies show that the CMV promoter reduces the neces-
sity for terminator elements, as termination on CbTERM and
CbDTERM is equivalent. However, a terminator element is still
required to terminate transcription of the EPO gene when the
CMV promoter is used. This could be accounted for by the differ-
ences in the EPO and b-globin pA signals. The strong b-globin
pA signal is rapidly processed to drive efficient pA site-depen-
dent termination on CbDTERM. However, the EPO pA signal is
not sufficiently strong to do the same on CEDTERM so that, in
this case, efficient Pol II termination depends on the terminator.
A strong pA signal may permit Pol II termination to occur when
transcription initiates from the CMV promoter, if elongation is
slow enough to negate the need for a pause element. Such
pause sites are normally needed for pA site cleavage-dependent
termination when transcription is from the HIV promoter. In
support of this being the case, CMV transcription promotes
splicing patterns that are typical of slow elongation (Cramer
et al., 1997). Furthermore, a higher percentage of b-globin exons
are cotranscriptionally splicedwhen transcription is driven by the
CMV promoter, as compared to when it is from the HIV promoter
(Figure S4). These data suggest that Pol II is less processive
when initiating at the CMV as compared to the HIV promoter,
which is known to promote highly efficient elongation (Nogues
et al., 2002; Parada and Roeder, 1996).
Our results show that a variety of unspliced pre-mRNA accu-
mulates when Pol II termination is inefficient, suggesting an influ-
ence of termination on pre-mRNA processing. Data in Figure 5
suggest that many introns may not be removed until after termi-
nation. Indeed, it has been shown that artificial release of pre-
mRNA from transcription sites can have a positive effect on
splicing of b-globin gene transcripts (Bird et al., 2005). We
have also shown that 30 end processing, another event with
a robust connection to transcription, can also occur posttran-
scriptionally (West et al., 2008). The present study shows that
when these processes occur after termination, the transcripts
are less susceptible to exosome degradation. Effectively, termi-
nation promotes escape from a nuclear surveillance process by
releasing transcripts from sites of synthesis, a theory substanti-
ated by our finding of high levels of released transcripts upon
termination (Figure 6D). Further evidence that termination may
be involved in mRNA release comes from experiments in yeast
which identify 30 end formation signals as important mediators
of RNA tethering to transcription sites (Abruzzi et al., 2006).
Unlike the situation in mammals, 30 end formation signals are
often the sole termination sequences in yeast.
We show in these studies that gene expression can be greatly
enhanced by transcriptional termination. As indicated in the
model (Figure 7), we predict that Pol II release from the DNA
template facilitates pre-mRNA processing and further allows
pre-mRNA/mRNA to escape surveillance. Our findings may
have wide-ranging implications for in vivo protein production.
This may be especially true in situations where efficient protein
expression is difficult or expensive to achieve. Efficient termina-
tion may also be required to optimize gene delivery for gene
therapy applications. It seems likely that Pol II termination repre-
sents a key stage in maintaining high levels of gene expression.
EXPERIMENTAL PROCEDURES
Nuclear Run-On Analysis
NRO and hybrid selection NRO have previously been described (Ashe et al.,
1997; Dye and Proudfoot, 1999). M13 probes were P, U3, and VA (Dye and
Proudfoot, 1999), B3 and B4 (Ashe et al., 1997), and A (West et al., 2004).
Template U3 selection probe was made by inserting an AvaI/PvuII restriction
fragment, from bTERM, into pGEM4, and the upstream U3 probe was made
by PCR amplification of bDTERM with primers U350 and U3T7. These clones
were transcribed by SP6 and T7 polymerase (Dye and Proudfoot, 1999). The
brUNRO protocol was performed as described (Lin et al., 2008).
Figure 7. Model
(Left) When termination is inefficient, pre-mRNA splicing is compromised and
polyadenylated RNA species (1 and 2) are retained at transcription sites. These
events are surveyed by the nuclear exosome, which degrades aberrant RNA
and reduces gene expression. (Right) Termination enhances gene expression
by promoting more efficient pre-mRNA processing and so reducing the
susceptibility of transcripts to degradation.
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RT-PCR
cDNAwasmade using SuperScript III (Invitrogen), and 1 ml of the 20 ml reaction
was analyzed by real-time PCR (10 pmol of each oligo, 1 ml of cDNA, 7.5 ml of
SYBR green mix [QIAGEN], and water to a final volume of 15 ml) or semiquan-
titative PCR (Taq polymerase, Bioline) (1 ml of 10 mM dNTPs, 10 pmol of each
primer, 1.5 mM magnesium chloride, 13 manufacturer’s buffer). Experiments
were quantitated after subtraction of values obtained from minus RT samples.
Western Blotting
Fifty percent of lysate from a confluent 5 cm dish of HeLa cells was used for
analysis. For secreted EPO, 10–100 ml of culture media was used. Membranes
were probed with anti-human b-globin (Santa Cruz Biotechnology) at 1:1000,
anti-EPO (Santa Cruz Biotechnology) at 1:1000, anti-PMScl100 (Abcam) at
1:1000, and anti-actin (Sigma) at 1:1000 or anti-HA (Santa Cruz Biotechnology)
at 1:1000. Secondary antibodies were anti-mouse (Sigma) at 1:2000 or anti-
rabbit (Sigma) at 1:2000. Signals were detected with an ECL kit (GE Health-
care) and quantitated using ImageQuant software.
Northern Blotting
The protocol is available at http://www.narrykim.org/Northern_blot_analysis_
for_microRNA.pdf. RNA samples were RNase H cleaved using primer 4.5
and dT. RNA was fractionated on a 6% gel and products were detected using
50 32P-labeled e3r primer.
Transfections
Semiconfluent HeLa cells, in 5 or 10 cm plates, were transfected with 1–5 mg of
reporter plasmid, 1–2 mg of VA plasmid, and 1.5 mg of Tat plasmid. Lipofect-
amine 2000 (Invitrogen) was used.
RNA Isolation
The procedures for isolating nuclear and cytoplasmic RNA (West and Proud-
foot, 2008) and for separating nuclear RNA into chromatin-associated and
released fractions (Dye et al., 2006) have been described.
Plasmids
Tat (Adams et al., 1988), VA (Dye and Proudfoot, 1999), and bTERM and
bDTERM (previously called bD5-7 and bD5-10) (Dye and Proudfoot, 2001);
bMAZ4, bZAM4, and bmMAZ4 (previously called pMAZ4, pZAM4, and
pmMAZ4) (Gromak et al., 2006); and ADTERM and balbTERM (previously
called bD5-10ApA and balb) plasmids (West et al., 2006b) have all been
described. ATERM was made by inserting a TERM50/TERM30 PCR product
into a vector prepared by PCR amplification of bD5-10ApA using APR/RTf
primers. PMDTERM and PMTERM were made by inserting a PCR product,
generated by PMF/PMR amplification of HeLa cell DNA, into vectors prepared
by F/e3 PCR amplification of bDTERM or bTERM, respectively. AMAZ4 was
made by inserting an APF/APR PCR product into a vector generated by
PCR amplification of bMAZ4 with the F/e3r primer pair. The EPO gene was
amplified from HeLa cell genomic DNA using primers E50/E30. EDTERM was
made by inserting EPO into a vector prepared by PCR amplification of
bDTERM with primers TAR30 and RTf. ETERM was made by inserting EPO
into a vector prepared by PCR amplification of bTERM using primers TAR30
and TERM50. The RBM21 expression plasmid was a kind gift from Chris Nor-
bury. RBM21 is a member of the recently discovered family of noncanonical
poly(A) polymerases. The bpA and MSA competition clones are described
elsewhere (West et al., 2006b). The PMScl100pA competition clone was
made by inserting a PMF/PMRPCR product into a vector made by PCR ampli-
fication of the bpA competition clone using primers SPAf and e3. For the CMV
promoter constructs, the HIV promoter was removed by an AvaI/AflII digest
and the CMV promoter, obtained by BglII/HindIII digest of pcDNA3.1 (Invitro-
gen), was inserted. bTERMm1 and bDTERMm1 were made by ligating a PCR
product generated by pAR/TERM50 and pAR/RTf amplification of HIVbIVS1-
SAmut (Dye and Proudfoot, 1999).
Nuclear RNA Fractionation
This protocol was previously described (Dye et al., 2006).
RNA Interference
RNA interference of PMScl100 was previously described (West et al., 2006a).
Primers
Primer sequences are in Table S1.
SUPPLEMENTAL DATA
The Supplemental Data include four figures and one table and can be found
with this article online at http://www.cell.com/molecular-cell/supplemental/
S1097-2765(09)00035-5.
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